Uniwersytecki Szpital Dzieciecy W Krakowie

At Uniwersytecki Szpital Dzieciecy W Krakowie, research in digestive system diseases focuses strongly on ulcerative colitis and Crohn’s disease in children and teenagers. These studies are designed to assess how well new and existing treatments control inflammation, support remission, and improve long-term disease management.

• Testing biologic and oral therapies for moderate to severe ulcerative colitis and Crohn’s disease
• Evaluating long-term safety and effectiveness of maintenance treatment in pediatric inflammatory bowel disease
• Studying therapies aimed at reducing intestinal inflammation and improving clinical remission

This work reflects a major clinical focus on helping young patients with chronic gastrointestinal conditions achieve better symptom control and quality of life.

The site also has a major research presence in hemic and lymphatic diseases, especially acute lymphoblastic leukemia, acute myeloid leukemia, and lymphoblastic lymphoma. The trials are centered on improving survival, reducing relapse risk, and making treatment safer for children and adolescents.

• Evaluating new treatment strategies for acute lymphoblastic leukemia and lymphoblastic lymphoma
• Testing approaches to improve outcomes in acute myeloid leukemia, including high-risk and relapsed disease
• Exploring ways to reduce treatment-related toxicity while preserving anti-cancer effectiveness

These studies support advanced pediatric cancer care through collaborative, disease-focused research at the hospital.

Clinical research in neoplasms includes important work on neuroblastoma and liver tumors such as hepatoblastoma and hepatocellular carcinoma. The goal is to improve outcomes for children with aggressive or hard-to-treat cancers through better treatment combinations and more effective disease control.

• Assessing new immunotherapy and chemotherapy combinations for high-risk neuroblastoma
• Studying treatment options for recurrent or resistant neuroblastoma
• Investigating therapy strategies for pediatric liver cancers, including hepatoblastoma

These trials aim to strengthen treatment effectiveness while supporting safer care for young patients with complex solid tumors.

Another key area at the Krakow pediatric hospital is nutritional and metabolic diseases and related kidney care, with studies in chronic kidney disease, anemia, proteinuric kidney disorders, and secondary hyperparathyroidism. Research here focuses on improving symptoms, correcting metabolic imbalances, and protecting kidney health in children.

• Evaluating treatments for anemia in children and adolescents with chronic kidney disease
• Studying therapies to reduce proteinuria in pediatric kidney disorders
• Assessing treatment options for secondary hyperparathyroidism in dialysis patients

This work aims to improve day-to-day health and long-term outcomes for children living with chronic renal disease.

The site conducts research in immune system diseases and related inflammatory processes, including chronic graft-versus-host disease, immune thrombocytopenia, and immune support with immunoglobulin therapy. These studies are intended to refine immune-based treatment and improve safety after intensive therapies.

• Testing therapies for chronic graft-versus-host disease after transplantation
• Evaluating treatment options for chronic idiopathic thrombocytopenic purpura
• Studying immunoglobulin replacement to help prevent serious infections in children with immune deficiency

Through these investigations, the site contributes to better management of immune-related complications in pediatric care.

Research at Uniwersytecki Szpital Dzieciecy W Krakowie also includes congenital, hereditary, and neonatal diseases, with a focus on rare conditions such as Mucopolysaccharidosis type II and Hunter syndrome. These trials examine treatments aimed at easing disease burden and improving neurological and physical symptoms.

• Evaluating therapies for MPS II and related inherited disorders
• Studying effects on central nervous system and body-wide symptoms
• Supporting long-term care research in rare pediatric metabolic disease

This area highlights the hospital’s role in advancing care for children with uncommon, lifelong conditions.

The hospital participates in research on hematopoietic stem cell transplantation and related supportive care, especially for children with acute lymphoblastic leukemia. These studies are designed to improve transplant outcomes, reduce complications, and maintain the anti-leukemia benefit of treatment.

• Optimizing transplant strategies for children and adolescents with ALL
• Assessing ways to lower treatment-related toxicity after HSCT
• Exploring supportive approaches to prevent relapse and manage transplant complications

This research supports safer and more effective transplant-based care for young patients with high-risk blood cancers.